Epidemiologic data of primary glomerular diseases in western France Pierre Simon, Marie-Paule Ramee, Rehouni Boulahrouz, Corina Stanescu, Christophe Charasse, K.I.M. Seng aNG, Françoise Leonetti, Gérard Cam, Eric Laruelle, Valérie Autuly, Nathalie Rioux Kidney International Volume 66, Issue 3, Pages 905-908 (September 2004) DOI: 10.1111/j.1523-1755.2004.00834.x Copyright © 2004 International Society of Nephrology Terms and Conditions
Figure 1 Renal biopsy indications according to period. Abbreviations are: ARF, acute renal failure; CRF, chronic renal failure; NS, nephrotic syndrome; P, proteinuria; H, hematuria; A, period A (1976 to 1985); B, period B (1986 to 1995); C, period C (1996 to 2002) (N = 663 renal biopsies during the period). Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions
Figure 2 Evolution of mean age at the time of renal biopsy years. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions
Figure 3 Annual incidence of primary glomerular disease (PGD) according to period and gender (incidence number/per million). Abbbreviations are: IsAN, IgA nephropathy (Bergers' disease); MN, membranous nephropathy; MC, minimal change; A, period A. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions
Figure 4 Annual incidence of primary glomerular disease (PGD) according to period and gender (incidence number/per million). Abbreviations are: MPGN, membranoproliferative glomerulonephritis type 1; acute PGN, poststreptococcal acute glomerulonephritis; crescentic PGN, idiopathic crescentic proliferative glomerulonephritis; A, period A. **P < 0.01; *P <0.05; +++P < 0.001 with period A. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions
Figure 5 Annual incidence of end-stage renal disease (ESRD) due to biopsied primary glomerular disease (PGD) according to period (incidence number/per million). Abbreviations are: Cresc. PGN, idiopathic crescentric proliferative glomerulonephritis; IgAN, IgA nephropathy; other, focal segmental glomerular sclerosis (with and without nephrotic syndrome, membranous nephropathy, membranoproliferative glomerulonephritis. ++P < 0.01. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions